Broadfin Capital as of March 31, 2017
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 52 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 11.9 | $99M | 6.7M | 14.78 | |
| Heron Therapeutics (HRTX) | 9.0 | $74M | 4.9M | 15.00 | |
| SPDR S&P Biotech (XBI) | 8.4 | $69M | 1.0M | 69.34 | |
| Retrophin | 6.5 | $53M | 2.9M | 18.46 | |
| Endo International (ENDPQ) | 5.2 | $43M | 3.9M | 11.16 | |
| Flamel Technologies Sa (AVDL) | 5.2 | $43M | 4.4M | 9.68 | |
| Recro Pharma (SCTL) | 3.3 | $27M | 3.1M | 8.74 | |
| AngioDynamics (ANGO) | 3.1 | $25M | 1.5M | 17.35 | |
| La Jolla Pharmaceuticl Com Par | 2.8 | $23M | 783k | 29.85 | |
| Ignyta | 2.8 | $23M | 2.6M | 8.60 | |
| Antares Pharma | 2.6 | $22M | 7.6M | 2.84 | |
| Progenics Pharmaceuticals | 2.6 | $21M | 2.2M | 9.44 | |
| Noveliontherapeuti.. | 2.5 | $21M | 1.9M | 10.74 | |
| Aratana Therapeutics | 2.4 | $20M | 3.7M | 5.30 | |
| Lion Biotechnologies | 2.3 | $19M | 2.5M | 7.45 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.9 | $16M | 8.2M | 1.95 | |
| Veracyte (VCYT) | 1.8 | $15M | 1.6M | 9.18 | |
| Teligent | 1.8 | $15M | 1.9M | 7.81 | |
| Strongbridge Bioph shs usd | 1.7 | $14M | 3.0M | 4.75 | |
| Advaxis | 1.5 | $12M | 1.5M | 8.17 | |
| Endologix | 1.5 | $12M | 1.7M | 7.24 | |
| Corium Intl | 1.4 | $12M | 2.8M | 4.18 | |
| Aralez Pharmaceuticals | 1.4 | $11M | 5.2M | 2.14 | |
| Mirati Therapeutics | 1.3 | $11M | 2.1M | 5.20 | |
| Medicines Company | 1.3 | $11M | 215k | 48.90 | |
| BioDelivery Sciences International | 1.2 | $10M | 5.4M | 1.90 | |
| Idera Pharmaceuticals | 1.1 | $9.5M | 3.9M | 2.47 | |
| Amarin Corporation (AMRN) | 1.1 | $9.1M | 2.8M | 3.20 | |
| DURECT Corporation | 1.1 | $8.9M | 8.5M | 1.05 | |
| Seaspine Holdings | 1.1 | $8.6M | 1.1M | 7.85 | |
| Egalet Corporation note 5.50% 4/1/20 | 1.0 | $8.2M | 10M | 0.82 | |
| C.R. Bard | 0.8 | $6.8M | 27k | 248.53 | |
| Adma Biologics (ADMA) | 0.6 | $5.0M | 1.0M | 4.88 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.5 | $4.4M | 1.1M | 3.89 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.5 | $4.4M | 563k | 7.80 | |
| Paratek Pharmaceuticals | 0.5 | $4.3M | 224k | 19.25 | |
| Dex (DXCM) | 0.5 | $4.2M | 49k | 84.73 | |
| Mediwound Ltd cmn | 0.5 | $4.2M | 633k | 6.60 | |
| Scynexis | 0.5 | $4.1M | 1.5M | 2.76 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.5 | $4.0M | 16M | 0.26 | |
| Juno Therapeutics | 0.5 | $3.9M | 176k | 22.19 | |
| Oncomed Pharmaceuticals | 0.3 | $2.8M | 300k | 9.21 | |
| Contrafect | 0.3 | $2.6M | 1.4M | 1.80 | |
| Aviragen Therapeutics | 0.2 | $2.1M | 3.2M | 0.65 | |
| Alcobra | 0.2 | $1.4M | 1.2M | 1.14 | |
| Cogentix Medical | 0.2 | $1.4M | 754k | 1.80 | |
| Avinger | 0.1 | $950k | 500k | 1.90 | |
| Windtree Therapeutics | 0.1 | $887k | 778k | 1.14 | |
| Aevi Genomic | 0.1 | $930k | 500k | 1.86 | |
| Dextera Surgical | 0.1 | $635k | 599k | 1.06 | |
| Strata Skin Sciences Incorporated | 0.1 | $587k | 961k | 0.61 | |
| Alphatec Holdings (ATEC) | 0.1 | $527k | 226k | 2.33 |
